• info@biointron.com
  • +86 400-828-8830
  • flag 中文简体 flag Japan
Taizhou Production Center.
  • Home
  • Antibody Discovery
    • Nanobody (VHH) Library Generation
    • Single B Cell Screening
    • Naïve Human Library
    • Hybridoma Sequencing
    • Antibody Humanization
  • Antibody Production
    • HTP Recombinant Antibody/VHH Production
    • Bispecific Antibody Production
    • Large Scale Antibody Production
    • Fast Antibody Production
  • Stable Cell Line
    • CHO-K1 Stable Cell line Generation
    • Commercial License for CHOK1BN
  • Protein Expression
    • Protein Expression In Mammalian
  • Catalogue Products
  • About Us
    • Company Overview
    • News
    • Promotions
    • Resources
    • Contact Us
    • Privacy Policy
Get Free Quote

Contact Info

  • G122 building, China Medical City, Taizhou, Jiangsu, China
  • info@biointron.com

News

Home About Us News

May 2-6 Biointron & PEGS BOSTON 2022 Booth: 213

  • Biointron
  • April-27-2022
  • 36 Visits
  • 13 Likes

conf-header-rotation3-scientist.jpg


Experience the Future of Biotherapeutic Drug Development

at the World’s Leading Biologics Event


May 2-6, 2022

HYNES CONVENTION CENTER

BOSTON,MA


Now in its eighteenth year, the PEGS Boston Summit is recognized as the leading international meeting place for the biotherapeutics community. PEGS Boston highlights a wide spectrum of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytical, immunogenicity, and more.

As we navigate the new realities of conferences and gatherings, you can count on CHI’s commitment to deliver quality content and facilitated networking opportunities to help achieve your research goals. Our new hybrid event model gives you the option to experience the summit safely in-person or securely online.

Join your peers and colleagues from around the world at PEGS Boston Summit to share insights, case studies, cutting-edge research, and form collaborations to advance biotherapeutics development.


Biotron Booth:213



Learn More>>

  • likes
  • oppose

Service

  • Nanobody (VHH) Library Generation
  • Single B Cell Screening
  • Naïve Human Library
  • HTP Recombinant Antibody/VHH Production
  • Bispecific Antibody Production
  • Hybridoma Sequencing
  • Antibody Humanization
  • Large Scale Antibody Production
  • CHO-K1 Stable Cell line Generation
  • Protein Expression In Mammalian
  • Fast Antibody Production
  • Commercial License for CHOK1BN

About us

  • Company Overview
  • News
  • Promotions
  • Resources
  • Contact Us
  • Privacy Policy

Contact us

  • Building 5,No.388 Galileo Road,Zhangjiang High-Tech Park,Shanghai
  • Email info@biointron.com
  • Support +86 400-828-8830

Copyright © 2022 Biointron. All rights reserved

X

Exercitation ullamco laboris nis aliquip sed conseqrure dolorn repreh deris ptate velit ecepteur duis.

Get in touch

  • G122 building, China Medical City, Taizhou, Jiangsu, China
  • info@biointron.com
  • +86 400-828-8830
  • Monday to Friday: 9am - 6pm